FILTERED RESULTS
FILTERS
Ads Top
•
·
·
FILTERED RESULTS
Anthropic's Pricing Shift Just Raised The Stakes For Palantir: Here's Why
AI Demand Surge Has No Cracks, Says Analyst
Aevex Stock Rockets On IPO Debut: Wall Street's New War Unicorn
TRUMP STATES IT IS 'HIGHLY UNLIKELY' THAT HE WILL EXTEND THE CEASEFIRE WITH IRAN....
Edge Hound Offers Affordable Market Intelligence for Retail Investors
Bank of Canada Reports Improved Business Sentiment Amid Global Uncertainty
Stifel Raises Intel Price Target to $65 Amid Recovery Signs
Intel Expected to Exceed Q1 Estimates Amid Strong CPU Demand
Western Digital Faces Financial Scrutiny Amid Strong Cash Flow
Intel Shares Surge Nearly 75% Year-to-Date Amid Recovery Efforts
Touchstone Funds Recognized with 2026 LSEG Lipper Awards
Fair Oaks Wealth Management Joins Ameriprise Financial
Dover Corporation Prepares for Q1 Earnings Release Amid Growth Forecasts
Markets Show Decline Ahead of New Week
Eli Lilly to Acquire Kelonia Therapeutics for $7 Billion
Mohawk Group Expands Flooring Portfolio with Hero Rubber
Novo Nordisk's Q1 Results Expected to Reflect Ozempic and Wegovy Sales
Philip Morris Secures Continued FDA Support for IQOS
AT&T Enhances In-Vehicle Connectivity with 4G and 5G Networks
STMicroelectronics Anticipates Revenue Growth Amid Mixed Market Conditions
Trump Warns of Potential Escalation in Iran if Ceasefire Ends
Germany Calls for De-escalation in Middle East Conflict
DOJ Steps Up Agriculture Market Scrutiny Amid Rising Prices
TRUMP BELIEVES A MEETING WITH IRAN COULD BENEFIT EVERYONE INVOLVED....
Iran considers US talks in Pakistan with blockade still unresolved
Poland stocks lower at close of trade; WIG30 down 1.07%
Turkey stocks lower at close of trade; BIST 100 down 0.71%
Bank of Canada survey: firms’ outlooks were improving before Iran war
Cannabis CEO Calls for Reform
Growing global imbalances risk ‘disorderly unwinding’ – panel
Braskem Majority Stake Sale by Novonor Advances With Signed Deal
Arm Holdings Collaborates with Rebellions and SK Telecom on AI Infrastructure
Wells Fargo Upgrades Biogen Stock to Overweight with Increased Price Target
Mizuho Increases Price Target for Robinhood Following SEC Regulatory Changes
Marvell Technology Shares Decline After Analyst Dispute on Google AI Chip Reports
AbbVie Stock Attracts Value Investors Amid Year-to-Date Decline
Barclays Upgrades Okta Amid Rising Demand for Identity Security
BP Stock Surges 59% Over the Past Year Amid Market Fluctuations
Bank of America Adjusts Meta Platforms Price Target While Maintaining Buy Rating
Digital Realty Prepares for Q1 Earnings with Positive Growth Projections
TGS Increases Fair Value Price Target to NOK104.49
Evercore ISI Includes Arista Networks and IBM in Tactical Outperform List
American Electric Power and NextEra Energy Positioned for Growth Amid Rising Electricity Demand
Raytheon Delivers Next Generation Jammer Pods to Royal Australian Air Force
TSMC Reports Record Q1 Profit Driven by AI Demand and Expands Global Operations
Data centre hopeful Fermi’s shares plunge as top executives quit
Marvell Stock Rises Amid AI Chip Talks with Google
Billionaires Continue to Invest in Key Stocks
AlphaTON Capital Rebrands as Alpha Compute, Focuses on AI Infrastructure
Abbott Laboratories Reports First-Quarter 2026 Results
Abbott Laboratories announced its financial results for the first quarter of 2026, stating that the outcomes were in line with the company's expectations for the beginning of the year. The report highlighted challenges faced by the company, particularly a decline in demand for respiratory testing.
Additionally, Abbott experienced earlier-than-anticipated financing costs associated with its recent acquisition of Exact Sciences. This acquisition is part of Abbott's strategy to enhance its portfolio and expand its capabilities in the healthcare sector.
© 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.
Source: KLEA News